Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL R French, O Hayward, S Jones, W Yang, R Clarkson Molecular cancer 14, 1-13, 2015 | 29 | 2015 |
The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer S Jones, G Farr, T Nimmanon, S Ziliotto, JMW Gee, KM Taylor Exploration of targeted anti-tumor therapy 3 (2), 224, 2022 | 11 | 2022 |
The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer S Kandil, F Prencipe, S Jones, S Hiscox, AD Westwell Chemical Biology & Drug Design 91 (1), 314-321, 2018 | 10 | 2018 |
Structure-based virtual screening, synthesis and biological evaluation of potential FAK-FAT domain inhibitors for treatment of metastatic cancer SB Kandil, SR Jones, S Smith, SE Hiscox, AD Westwell Molecules 25 (15), 3488, 2020 | 9 | 2020 |
Exploring Focal Adhesion Kinase (FAK) as a therapeutic target in triple negative breast cancer SR Jones Cardiff University, 2017 | 1 | 2017 |
Methods to visualise zinc transporter proteins of the SLC39A family in cells G Farr, S Jones, KM Taylor Methods in Enzymology 687, 67-85, 2023 | | 2023 |
Characterizing the cellular uptake of neural stem-cell derived exosomes using live-cell imaging techniques Jones, Samuel: Caws, Thomas: Hayes, Anthony: Durban, Victoria Marsh ... ISEV annual meeting 2019 8, 129, 2019 | | 2019 |
Targeting metastasis and cancer stem-like cells in triple negative breast cancer through inhibition of focal adhesion kinase S Jones, C Smith, S Hiscox, WG Jiang Cancer Research 76 (14_Supplement), 4125-4125, 2016 | | 2016 |